KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Net Cash Flow (2016 - 2026)

AbbVie has reported Net Cash Flow over the past 14 years, most recently at -$411.0 million for Q4 2025.

  • Quarterly Net Cash Flow rose 75.64% to -$411.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$337.0 million through Dec 2025, up 95.34% year-over-year, with the annual reading at -$337.0 million for FY2025, 95.34% up from the prior year.
  • Net Cash Flow was -$411.0 million for Q4 2025 at AbbVie, up from -$830.0 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $5.3 billion in Q1 2024 and troughed at -$5.9 billion in Q3 2024.
  • The 5-year median for Net Cash Flow is -$453.5 million (2023), against an average of -$152.2 million.
  • Year-over-year, Net Cash Flow tumbled 552.63% in 2021 and then soared 311.01% in 2024.
  • A 5-year view of Net Cash Flow shows it stood at -$2.4 billion in 2021, then fell by 10.22% to -$2.7 billion in 2022, then skyrocketed by 81.31% to -$496.0 million in 2023, then plummeted by 240.12% to -$1.7 billion in 2024, then skyrocketed by 75.64% to -$411.0 million in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Net Cash Flow are -$411.0 million (Q4 2025), -$830.0 million (Q3 2025), and $1.3 billion (Q2 2025).